Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
- Author
- Bert Vander Cruyssen (UGent) , R WESTHOVENS, P DUREZ, L DE CLERCK, A PERETZ, L VERBRUGGEN, N VASTESAEGER, W NOEL and F DE KEYSER
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-432676
- MLA
- Vander Cruyssen, Bert, et al. “Tapering Infliximab Dosages after Temporary Dose Increase Does Not Affect Treatment Survival in an Established RA Population.” RHEUMATOLOGY, vol. 47, 2008, p. 39.
- APA
- Vander Cruyssen, B., WESTHOVENS, R., DUREZ, P., DE CLERCK, L., PERETZ, A., VERBRUGGEN, L., … DE KEYSER, F. (2008). Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population. RHEUMATOLOGY, 47, 39.
- Chicago author-date
- Vander Cruyssen, Bert, R WESTHOVENS, P DUREZ, L DE CLERCK, A PERETZ, L VERBRUGGEN, N VASTESAEGER, W NOEL, and F DE KEYSER. 2008. “Tapering Infliximab Dosages after Temporary Dose Increase Does Not Affect Treatment Survival in an Established RA Population.” In RHEUMATOLOGY, 47:39.
- Chicago author-date (all authors)
- Vander Cruyssen, Bert, R WESTHOVENS, P DUREZ, L DE CLERCK, A PERETZ, L VERBRUGGEN, N VASTESAEGER, W NOEL, and F DE KEYSER. 2008. “Tapering Infliximab Dosages after Temporary Dose Increase Does Not Affect Treatment Survival in an Established RA Population.” In RHEUMATOLOGY, 47:39.
- Vancouver
- 1.Vander Cruyssen B, WESTHOVENS R, DUREZ P, DE CLERCK L, PERETZ A, VERBRUGGEN L, et al. Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population. In: RHEUMATOLOGY. 2008. p. 39.
- IEEE
- [1]B. Vander Cruyssen et al., “Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population,” in RHEUMATOLOGY, 2008, vol. 47, p. 39.
@inproceedings{432676,
author = {{Vander Cruyssen, Bert and WESTHOVENS, R and DUREZ, P and DE CLERCK, L and PERETZ, A and VERBRUGGEN, L and VASTESAEGER, N and NOEL, W and DE KEYSER, F}},
booktitle = {{RHEUMATOLOGY}},
issn = {{1462-0324}},
language = {{eng}},
pages = {{II39-II39}},
title = {{Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population}},
volume = {{47}},
year = {{2008}},
}